Dry Bulk Shipping
Dry Bulk Shipping market is segmented by players, region (country), by Type and by Application. P ... Read More
Global Drug-Eluting Stents Market Research Report 2024
1 Drug-Eluting Stents Market Overview
1.1 Product Overview and Scope of Drug-Eluting Stents
1.2 Drug-Eluting Stents Segment by Type
1.2.1 Global Drug-Eluting Stents Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Rapamycin
1.2.3 Paclitaxel
1.2.4 Everolimus
1.2.5 Others
1.3 Drug-Eluting Stents Segment by Application
1.3.1 Global Drug-Eluting Stents Sales Comparison by Application: (2022-2028)
1.3.2 Angina Pectoris
1.3.3 Myocardial Infarction
1.4 Global Drug-Eluting Stents Market Size Estimates and Forecasts
1.4.1 Global Drug-Eluting Stents Revenue 2017-2028
1.4.2 Global Drug-Eluting Stents Sales 2017-2028
1.4.3 Drug-Eluting Stents Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drug-Eluting Stents Market Competition by Manufacturers
2.1 Global Drug-Eluting Stents Sales Market Share by Manufacturers (2017-2022)
2.2 Global Drug-Eluting Stents Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Drug-Eluting Stents Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Drug-Eluting Stents Manufacturing Sites, Area Served, Product Type
2.5 Drug-Eluting Stents Market Competitive Situation and Trends
2.5.1 Drug-Eluting Stents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug-Eluting Stents Players Market Share by Revenue
2.5.3 Global Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug-Eluting Stents Retrospective Market Scenario by Region
3.1 Global Drug-Eluting Stents Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Drug-Eluting Stents Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Drug-Eluting Stents Market Facts & Figures by Country
3.3.1 North America Drug-Eluting Stents Sales by Country
3.3.2 North America Drug-Eluting Stents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug-Eluting Stents Market Facts & Figures by Country
3.4.1 Europe Drug-Eluting Stents Sales by Country
3.4.2 Europe Drug-Eluting Stents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug-Eluting Stents Market Facts & Figures by Region
3.5.1 Asia Pacific Drug-Eluting Stents Sales by Region
3.5.2 Asia Pacific Drug-Eluting Stents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug-Eluting Stents Market Facts & Figures by Country
3.6.1 Latin America Drug-Eluting Stents Sales by Country
3.6.2 Latin America Drug-Eluting Stents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug-Eluting Stents Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug-Eluting Stents Sales by Country
3.7.2 Middle East and Africa Drug-Eluting Stents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Drug-Eluting Stents Historic Market Analysis by Type
4.1 Global Drug-Eluting Stents Sales Market Share by Type (2017-2022)
4.2 Global Drug-Eluting Stents Revenue Market Share by Type (2017-2022)
4.3 Global Drug-Eluting Stents Price by Type (2017-2022)
5 Global Drug-Eluting Stents Historic Market Analysis by Application
5.1 Global Drug-Eluting Stents Sales Market Share by Application (2017-2022)
5.2 Global Drug-Eluting Stents Revenue Market Share by Application (2017-2022)
5.3 Global Drug-Eluting Stents Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boston Scientific Drug-Eluting Stents Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic, Inc.
6.2.1 Medtronic, Inc. Corporation Information
6.2.2 Medtronic, Inc. Description and Business Overview
6.2.3 Medtronic, Inc. Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Medtronic, Inc. Drug-Eluting Stents Product Portfolio
6.2.5 Medtronic, Inc. Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Abbott Drug-Eluting Stents Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Lepu Medical Drug-Eluting Stents Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 MicroPort Scientific Corporation
6.5.1 MicroPort Scientific Corporation Corporation Information
6.5.2 MicroPort Scientific Corporation Description and Business Overview
6.5.3 MicroPort Scientific Corporation Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.5.4 MicroPort Scientific Corporation Drug-Eluting Stents Product Portfolio
6.5.5 MicroPort Scientific Corporation Recent Developments/Updates
6.6 Cook Medical
6.6.1 Cook Medical Corporation Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Cook Medical Drug-Eluting Stents Product Portfolio
6.6.5 Cook Medical Recent Developments/Updates
6.7 Terumo
6.6.1 Terumo Corporation Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Terumo Drug-Eluting Stents Product Portfolio
6.7.5 Terumo Recent Developments/Updates
6.8 Biosensors International
6.8.1 Biosensors International Corporation Information
6.8.2 Biosensors International Description and Business Overview
6.8.3 Biosensors International Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Biosensors International Drug-Eluting Stents Product Portfolio
6.8.5 Biosensors International Recent Developments/Updates
6.9 Balton
6.9.1 Balton Corporation Information
6.9.2 Balton Description and Business Overview
6.9.3 Balton Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Balton Drug-Eluting Stents Product Portfolio
6.9.5 Balton Recent Developments/Updates
6.10 AlviMedica Medical Technologies
6.10.1 AlviMedica Medical Technologies Corporation Information
6.10.2 AlviMedica Medical Technologies Description and Business Overview
6.10.3 AlviMedica Medical Technologies Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.10.4 AlviMedica Medical Technologies Drug-Eluting Stents Product Portfolio
6.10.5 AlviMedica Medical Technologies Recent Developments/Updates
6.11 Biotronik
6.11.1 Biotronik Corporation Information
6.11.2 Biotronik Drug-Eluting Stents Description and Business Overview
6.11.3 Biotronik Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Biotronik Drug-Eluting Stents Product Portfolio
6.11.5 Biotronik Recent Developments/Updates
6.12 Shandong JW Medical
6.12.1 Shandong JW Medical Corporation Information
6.12.2 Shandong JW Medical Drug-Eluting Stents Description and Business Overview
6.12.3 Shandong JW Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shandong JW Medical Drug-Eluting Stents Product Portfolio
6.12.5 Shandong JW Medical Recent Developments/Updates
6.13 Sino Medical
6.13.1 Sino Medical Corporation Information
6.13.2 Sino Medical Drug-Eluting Stents Description and Business Overview
6.13.3 Sino Medical Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Sino Medical Drug-Eluting Stents Product Portfolio
6.13.5 Sino Medical Recent Developments/Updates
6.14 Beijing AMSINO
6.14.1 Beijing AMSINO Corporation Information
6.14.2 Beijing AMSINO Drug-Eluting Stents Description and Business Overview
6.14.3 Beijing AMSINO Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Beijing AMSINO Drug-Eluting Stents Product Portfolio
6.14.5 Beijing AMSINO Recent Developments/Updates
6.15 Liaoning Biomedical Materials R&D Center Co.(LBC)
6.15.1 Liaoning Biomedical Materials R&D Center Co.(LBC) Corporation Information
6.15.2 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Description and Business Overview
6.15.3 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Product Portfolio
6.15.5 Liaoning Biomedical Materials R&D Center Co.(LBC) Recent Developments/Updates
7 Drug-Eluting Stents Manufacturing Cost Analysis
7.1 Drug-Eluting Stents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug-Eluting Stents
7.4 Drug-Eluting Stents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug-Eluting Stents Distributors List
8.3 Drug-Eluting Stents Customers
9 Drug-Eluting Stents Market Dynamics
9.1 Drug-Eluting Stents Industry Trends
9.2 Drug-Eluting Stents Market Drivers
9.3 Drug-Eluting Stents Market Challenges
9.4 Drug-Eluting Stents Market Restraints
10 Global Market Forecast
10.1 Drug-Eluting Stents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug-Eluting Stents by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Drug-Eluting Stents by Type (2023-2028)
10.2 Drug-Eluting Stents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug-Eluting Stents by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Drug-Eluting Stents by Application (2023-2028)
10.3 Drug-Eluting Stents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug-Eluting Stents by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Drug-Eluting Stents by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Drug-Eluting Stents Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Drug-Eluting Stents Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Drug-Eluting Stents Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Drug-Eluting Stents Market Competitive Situation by Manufacturers in 2021
Table 5. Global Drug-Eluting Stents Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Drug-Eluting Stents Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Drug-Eluting Stents Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Drug-Eluting Stents Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Drug-Eluting Stents Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Drug-Eluting Stents Manufacturing Sites and Area Served
Table 11. Manufacturers Drug-Eluting Stents Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug-Eluting Stents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug-Eluting Stents as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug-Eluting Stents Sales by Region (2017-2022) & (K Units)
Table 16. Global Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Table 17. Global Drug-Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Table 19. North America Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 20. North America Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 21. North America Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 23. Europe Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 24. Europe Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 25. Europe Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Drug-Eluting Stents Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Drug-Eluting Stents Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Table 31. Latin America Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 33. Latin America Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Drug-Eluting Stents Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Drug-Eluting Stents Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Drug-Eluting Stents Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Drug-Eluting Stents Revenue Market Share by Country (2017-2022)
Table 39. Global Drug-Eluting Stents Sales by Type (2017-2022) & (K Units)
Table 40. Global Drug-Eluting Stents Sales Market Share by Type (2017-2022)
Table 41. Global Drug-Eluting Stents Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Drug-Eluting Stents Revenue Share by Type (2017-2022)
Table 43. Global Drug-Eluting Stents Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Drug-Eluting Stents Sales (K Units) by Application (2017-2022)
Table 45. Global Drug-Eluting Stents Sales Market Share by Application (2017-2022)
Table 46. Global Drug-Eluting Stents Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Drug-Eluting Stents Revenue Share by Application (2017-2022)
Table 48. Global Drug-Eluting Stents Price by Application (2017-2022) & (USD/Unit)
Table 49. Boston Scientific Corporation Information
Table 50. Boston Scientific Description and Business Overview
Table 51. Boston Scientific Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Boston Scientific Drug-Eluting Stents Product
Table 53. Boston Scientific Recent Developments/Updates
Table 54. Medtronic, Inc. Corporation Information
Table 55. Medtronic, Inc. Description and Business Overview
Table 56. Medtronic, Inc. Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Medtronic, Inc. Drug-Eluting Stents Product
Table 58. Medtronic, Inc. Recent Developments/Updates
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Business Overview
Table 61. Abbott Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Abbott Drug-Eluting Stents Product
Table 63. Abbott Recent Developments/Updates
Table 64. Lepu Medical Corporation Information
Table 65. Lepu Medical Description and Business Overview
Table 66. Lepu Medical Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Lepu Medical Drug-Eluting Stents Product
Table 68. Lepu Medical Recent Developments/Updates
Table 69. MicroPort Scientific Corporation Corporation Information
Table 70. MicroPort Scientific Corporation Description and Business Overview
Table 71. MicroPort Scientific Corporation Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. MicroPort Scientific Corporation Drug-Eluting Stents Product
Table 73. MicroPort Scientific Corporation Recent Developments/Updates
Table 74. Cook Medical Corporation Information
Table 75. Cook Medical Description and Business Overview
Table 76. Cook Medical Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Cook Medical Drug-Eluting Stents Product
Table 78. Cook Medical Recent Developments/Updates
Table 79. Terumo Corporation Information
Table 80. Terumo Description and Business Overview
Table 81. Terumo Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Terumo Drug-Eluting Stents Product
Table 83. Terumo Recent Developments/Updates
Table 84. Biosensors International Corporation Information
Table 85. Biosensors International Description and Business Overview
Table 86. Biosensors International Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Biosensors International Drug-Eluting Stents Product
Table 88. Biosensors International Recent Developments/Updates
Table 89. Balton Corporation Information
Table 90. Balton Description and Business Overview
Table 91. Balton Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Balton Drug-Eluting Stents Product
Table 93. Balton Recent Developments/Updates
Table 94. AlviMedica Medical Technologies Corporation Information
Table 95. AlviMedica Medical Technologies Description and Business Overview
Table 96. AlviMedica Medical Technologies Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. AlviMedica Medical Technologies Drug-Eluting Stents Product
Table 98. AlviMedica Medical Technologies Recent Developments/Updates
Table 99. Biotronik Corporation Information
Table 100. Biotronik Description and Business Overview
Table 101. Biotronik Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Biotronik Drug-Eluting Stents Product
Table 103. Biotronik Recent Developments/Updates
Table 104. Shandong JW Medical Corporation Information
Table 105. Shandong JW Medical Description and Business Overview
Table 106. Shandong JW Medical Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Shandong JW Medical Drug-Eluting Stents Product
Table 108. Shandong JW Medical Recent Developments/Updates
Table 109. Sino Medical Corporation Information
Table 110. Sino Medical Description and Business Overview
Table 111. Sino Medical Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Sino Medical Drug-Eluting Stents Product
Table 113. Sino Medical Recent Developments/Updates
Table 114. Beijing AMSINO Corporation Information
Table 115. Beijing AMSINO Description and Business Overview
Table 116. Beijing AMSINO Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Beijing AMSINO Drug-Eluting Stents Product
Table 118. Beijing AMSINO Recent Developments/Updates
Table 119. Liaoning Biomedical Materials R&D Center Co.(LBC) Corporation Information
Table 120. Liaoning Biomedical Materials R&D Center Co.(LBC) Description and Business Overview
Table 121. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Liaoning Biomedical Materials R&D Center Co.(LBC) Drug-Eluting Stents Product
Table 123. Liaoning Biomedical Materials R&D Center Co.(LBC) Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Drug-Eluting Stents Distributors List
Table 127. Drug-Eluting Stents Customers List
Table 128. Drug-Eluting Stents Market Trends
Table 129. Drug-Eluting Stents Market Drivers
Table 130. Drug-Eluting Stents Market Challenges
Table 131. Drug-Eluting Stents Market Restraints
Table 132. Global Drug-Eluting Stents Sales Forecast by Type (2023-2028) & (K Units)
Table 133. Global Drug-Eluting Stents Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Drug-Eluting Stents Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Drug-Eluting Stents Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Drug-Eluting Stents Sales Forecast by Application (2023-2028) & (K Units)
Table 137. Global Drug-Eluting Stents Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Drug-Eluting Stents Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Drug-Eluting Stents Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Drug-Eluting Stents Sales Forecast by Region (2023-2028) & (K Units)
Table 141. Global Drug-Eluting Stents Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Drug-Eluting Stents Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Drug-Eluting Stents Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug-Eluting Stents
Figure 2. Global Drug-Eluting Stents Market Share by Type in 2021 & 2028
Figure 3. Rapamycin Product Picture
Figure 4. Paclitaxel Product Picture
Figure 5. Everolimus Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug-Eluting Stents Market Share by Application in 2021 & 2028
Figure 8. Angina Pectoris
Figure 9. Myocardial Infarction
Figure 10. Global Drug-Eluting Stents Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Drug-Eluting Stents Market Size (2017-2028) & (US$ Million)
Figure 12. Global Drug-Eluting Stents Sales (2017-2028) & (K Units)
Figure 13. Drug-Eluting Stents Sales Share by Manufacturers in 2021
Figure 14. Global Drug-Eluting Stents Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Drug-Eluting Stents Players: Market Share by Revenue in 2021
Figure 16. Drug-Eluting Stents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Drug-Eluting Stents Sales Market Share by Region (2017-2022)
Figure 18. Global Drug-Eluting Stents Sales Market Share by Region in 2021
Figure 19. Global Drug-Eluting Stents Revenue Market Share by Region (2017-2022)
Figure 20. Global Drug-Eluting Stents Revenue Market Share by Region in 2021
Figure 21. U.S. Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Taiwan Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Philippines Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Vietnam Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Mexico Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Brazil Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Argentina Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. U.A.E Drug-Eluting Stents Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Drug-Eluting Stents by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Drug-Eluting Stents
Figure 47. Manufacturing Process Analysis of Drug-Eluting Stents
Figure 48. Drug-Eluting Stents Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Boston Scientific Medtronic, Inc. Abbott Lepu Medical MicroPort Scientific Corporation Cook Medical Terumo Biosensors International Balton AlviMedica Medical Technologies Biotronik Shandong JW Medical Sino Medical Beijing AMSINO Liaoning Biomedical Materials R&D Center Co.(LBC)